Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018

SELL
$244.1 - $303.88 $117,900 - $146,774
-483 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$233.97 - $274.11 $113,007 - $132,395
483 New
483 $121,000
Q4 2017

Feb 14, 2018

SELL
$216.94 - $271.3 $137,106 - $171,461
-632 Closed
0 $0
Q3 2017

Nov 14, 2017

SELL
$212.27 - $242.28 $56,888 - $64,931
-268 Reduced 29.78%
632 $140,000
Q2 2017

Aug 14, 2017

BUY
N/A
900
900 $204,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.47B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Natixis Investment Managers International Portfolio

Follow Natixis Investment Managers International and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

News

Stay updated on Natixis Investment Managers International with notifications on news.